Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)(1A) receptors: Way 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535

Synapse

Volumn 30, Issue 2, 1998, Pages 172-180

  Lejeune, Françoise ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Autoreceptor; Depres sion; Dopamine; Dorsal raphe nucleus; Extracellular unit activity; Frontal cortex

Indexed keywords

FLESINOXAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG RECEPTOR BINDING; FACILITATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEURONS; PIPERAZINES; PREFRONTAL CORTEX; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VENTRAL TEGMENTAL AREA;

EID: 0031815815     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9     Document Type: Article

References (65)

1. Aghajanian, G.K., Wang, R.Y., and Baraban, J. (1978) Serotonergic and non-serotonergic neurones of the dorsal raphe: Reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res., 153:169-175.
2. Ahlenius, S., Hillegaart, V., and Wijkström, A. (1990) Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J. Pharm. Pharmacol., 42:285-288.
3. Arborelius, L., Nomikos, G.G., Hacksell, U., and Svensson, T.H. (1993a) (R)-8-OH-DPAT preferentially increases DA release in the rat medial prefrontal cortex. Acta Physiol. Scand., 148:465-466.
4. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmiedebergs Arch. Pharmacol., 347:353-362.
5. Assie, M.B., and Koek, W. (1996) Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br. J. Pharmacol., 119:845-850.
6. Benloucif, S., Keegan, M.J., and Galloway, M.P. (1993) Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther, 265:372-377.
7. 1A receptors. J. Neurochem., 66:2546-2555.
8. Cameron, D.L., Wessendorf, M. W., and Willians, J.T. (1997) A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience, 77:155-166.
9. Ceci, A., Baschirotto, A., and Borsini, F. (1994) The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotonergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology, 33:709-713.
10. 1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur. J. Pharmacol., 158:53-59.
11. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse, 10:264-266.
12. Chen, N.-H., and Reith, E.A. (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem., 641:1585-1597.
13. De Simoni, M.G., Dal Toso, G., Fodritto, F., Sokola, A., and Algeri, S. (1987) Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences. Brain Res., 411:81-88.
14. 1A receptor antagonist. Behav. Brain Res., 73:337-353.
15. Fletcher, P.J. (1991) Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe. Brain Res., 552:181-189.
16. Giambalo, G.T., and Snodgrass, S.R. (1978) Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: Comparison of injection sites. Brain Res., 152:555-566.
17. Gobert, A., Lejeune, F., Rivet, J.-M., Audinot, V., Newman-Tancredi, A., and Millan, M.J. (1995) Mdulation of the activity of central serotonergic neurons by novel serotonin 1A receptor agonists and antagonists: A comparison to adrenergic and dopaminergic neurones in rats. J. Pharmacol. Exp. Ther., 273:1032-1046.
18. 3 (auto)receptors inhibits dopamine release in the frontal cortex of freely moving rats in vivo. J. Neurochem., 66:2209-2212.
19. Gobert, A., Rivet, J.-M., Audinot, V., Newman-Tancredi, A., and Millan, M.J. (1998) Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and hetero-receptor mediated control of release. Neuroscience, 84:413-429.
20. Gobert, A., Rivet, J.-M., Cistarelli, L., and Millan, M.J. (1997) Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. J. Neurochem., 68:1326-1329.
21. 1A receptors in rat brain membranes. Eur. J. Pharmacol., 288:173-186.
22. 1A receptor agonist, are not related to its neuroendocrine effects. Eur. J. Pharmacol., 280:185-193.
23. 1A receptor agonist, in the treatment-resistant depression. Int. Clin. Psychopharmacol., 8:167-172.
24. Guan, X.-M., and McBride, W.J. (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull., 23:541-547.
25. 1A properties of flesinoxan: In vivo electrophysiology and hypothermia study. Neuropharmacology, 34:1311-1326.
26. Hervé, D., Pickel, V.M., Joh, T.H., and Beaudet, A. (1987) Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res., 435:71-83.
27. B synaptic potential in rat dopamine neurones J. Neurosci., 12:2000-2006.
28. Kalivas, P.W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev., 18:75-113.
29. Kelland, M.D., and Chiodo, L.A. (1996) Serotonergic modulation of midbrain dopamine systems. In: The Modulation of Dopaminergic Neurotransmission by Other Neurotransmitters. C.R. Ashby, Jr., ed. Boca Raton, New York, London, and Tokyo: CRC Press, pp 87-122.
30. 2 receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines. J. Med. Chem., 40:300-312.
31. 1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. Eur. J. Pharmacol., 249:25-35.
32. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurons in vivo. Eur. J. Pharmacol., 275:7.
33. 1A receptors and their modulation of the activity of serotonergic and dopaminergic neurones in the rat. J. Pharmacol. Exp. Ther., 280:1241-1249.
34. 2C receptors modulate the activity of mesocortical and mesolimbic dopaminergic pathways: Acombined dialysis and electrophysiological analysis. Soc. Neurosci. Abstr., 23:875.
35. Maes, M., and Meltzer, H.Y. (1995) The serotonin hypothesis of major depression. In: Psychopharmacology: The Fourth Generation in Progress. F.E. Bloom and D.J. Kupfer, eds. New York: Raven Press, pp 933-944.
36. 1A agonists. Mol. Pharmacol., 37:231-237.
37. Meltzer, H.Y. (1989) Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berlin), 99:18.
38. 1C/2 receptors. J. Pharmacol. Exp. Ther., 262: 451-463.
39. 1A antagonists. J. Pharmacol. Exp. Ther., 268:337-352.
40. 2A-adrenergic receptors in relation to modulation of cortical monoamine release and potential antidepressant properties. J. Pharmacol. Exp. Ther., 282:132-147.
41. 1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J. Pharmacol. Exp. Ther., 282:148-161.
42. Millan, M.J., and Gobert, A. (1997c) Autoreceptor and heteroreceptor control of serotonin (5-HT), dopamine (DA) and noradrenaline (NAD) release in the frontal cortex: Strategies for improved antidepressant agents. Br. J. Pharmacol., 122:468P.
43. Molewijk, H.E., van der Poel, A.M., Mos, J., van der Heyden, J.A.M., and Olivier, B. (1995) Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening antipanic drugs. Psychopharmacology (Berlin), 117:32-40.
44. 1A receptors. Eur. J. Pharmacol., 307:107-111.
45. Papp, M., and Willner, P. (1991) 8-OH-DPAT-induced place preference and place aversion: Effects of PCPA and dopamine antagonists. Psychopharmacology (Berlin), 103:99-102.
46. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol., 45:375-383.
47. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic Press.
48. Pazos, A., and Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Serotonin-1 receptors. Brain Res., 346:205-230.
49. Pessia, M., Jiang, Z.-G., North, R.A., and Johnson, S.W. (1994) Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res., 654:324-330.
50. 1A receptor challenge in major depression and suicidal behevior. Pharmacopsychiatry, 28:91-92.
51. Prisco, S., Pagannone, S., and Esposito, E. (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo. J. Pharmacol. Exp. Ther., 271:83-90.
52. 1A agonist (±)-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse, 18:218-224.
53. 1A receptor agonist, flesinoxan. Pharmacol. Biochem. Behav., 48:959-963.
54. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J.M., Schwartz, J.-C. (1993) Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT-) activating cAMP formation. Proc. Natl. Acad. Sci. USA, 90:8547-8551.
55. 1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Pharmacol. Biochem. Behav., 51:211-215.
56. 1-adrenoceptor antagonism. J. Clin. Psychopharmacol., 15:11-18.
57. Tanda, G., Carboni, E., Frau, R., and Di Chiara, G. (1994) Increase of extracellular dopamine in the prefrontal cortex: Atrait of drugs with antidepressant potential? Psychopharmacology (Berlin), 115:285-288.
58. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology (Berlin), 119:15-19.
59. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology (Berlin), 98:45-50.
60. Wang, R.Y. (1981) Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res. Rev., 3:123-140.
61. 1A receptors in the rat prefrontal cortex. Eur. J. Pharmacol., 305:73-78.
62. Willner, P. (1995) Dopaminergic mechanisms in depression and mania. In: Psychopharmacology: The Fourth Generation in Progress. F.E. Bloom and D.J. Kupfer, eds. New York: Raven Press, pp 921-931.
63. Yoshimoto, K., and McBride, W.J. (1992) Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res., 17:401-407.
64. Zacharko, R.M., and Anisman, H. (1991) Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev., 15:391-405.
65. 1A agonist, 8-OH-DPAT, on midbrain DA neurons: A9/A10 differences. Soc. Neurosci. Abstr., 19:1373.